Woman wins court battle for breast cancer treatment
· Patient hails ruling that has 'given back her future' · Primary care trusts still allowed to refuse drug
‘It’s not such a brave new world, after all’
For the past 18 months, Dina Rabinovitch has been writing regular articles in G2 about her treatment for breast cancer. Recently, she noticed a red rash around her mastectomy scar. But she had already guessed that the cancer had returned.
Surgeon ‘could have put breast cancer patients at risk’
· Expert says women less likely to get radiotherapy · Trust rejects findings of higher death rates
The selling of a wonder drug
Four years ago, almost no one had heard of it. Today, Herceptin is a household name and women with early-stage breast cancer are going to court for the right to get it. Yet the drug is not actually licensed for use in early-stage cancer - and the clinical tests, while promising, don't yet prove it will ever save lives. How did Herceptin become a cause celebre? Sarah Boseley investigates.
New pill promises to reduce breast cancer risk
· Controversial ingredient could aid PMT sufferers· Anti-abortion groups challenge safety record
Women go private to get ‘miracle’ drug
Victims of breast cancer may be able to claim for Herceptin on their health insurance, writes Jill Insley.
Going for the burn
In some parts of Britain, skin cancer rates are now higher than in Australia. And all because we just love to be brown ... Oliver Burkeman on our unhealthy obsession with tanning.